Abdomen

"Anti-Choke Mug" - Chula Innovation for Neuro Patients to Drink Water Confidently

Retrieved on: 
Wednesday, November 29, 2023

Choking in these patients can cause pneumonia, lung infections, sepsis, and eventually death, so it should not be overlooked by patients and caregivers.

Key Points: 
  • Choking in these patients can cause pneumonia, lung infections, sepsis, and eventually death, so it should not be overlooked by patients and caregivers.
  • "One of the problems for the elderly is incomplete swallowing, and there is some food residue remaining in the oral cavity.
  • Ensure that the patient is mindful of eating and drinking water, concentrating on eating and swallowing all the food.
  • Anti-choke mugs – help ease swallowing, reducing the chance of choking
    As behavioral changes for swallowing is difficult for both patients and caregivers, the research team then developed an "anti-choke mug" to help patients drink water safely.

"Anti-Choke Mug" - Chula Innovation for Neuro Patients to Drink Water Confidently

Retrieved on: 
Wednesday, November 29, 2023

Choking in these patients can cause pneumonia, lung infections, sepsis, and eventually death, so it should not be overlooked by patients and caregivers.

Key Points: 
  • Choking in these patients can cause pneumonia, lung infections, sepsis, and eventually death, so it should not be overlooked by patients and caregivers.
  • "One of the problems for the elderly is incomplete swallowing, and there is some food residue remaining in the oral cavity.
  • Ensure that the patient is mindful of eating and drinking water, concentrating on eating and swallowing all the food.
  • Anti-choke mugs – help ease swallowing, reducing the chance of choking
    As behavioral changes for swallowing is difficult for both patients and caregivers, the research team then developed an "anti-choke mug" to help patients drink water safely.

United Imaging Showcases Pioneering Advances and Reinforces U.S. Growth at RSNA 2023

Retrieved on: 
Tuesday, November 21, 2023

HOUSTON, Nov. 21, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is set to showcase its comprehensive portfolio of innovative technologies at RSNA 2023.

Key Points: 
  • HOUSTON, Nov. 21, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is set to showcase its comprehensive portfolio of innovative technologies at RSNA 2023.
  • Highlighting this growth at RSNA 2023, United Imaging will feature the uMR Jupiter 5T (510k pending; not available commercially in the U.S.), a revolutionary whole-body 5T MRI system.
  • In recognition of exceptional scientific contributions, United Imaging takes pride in celebrating Lingzhi (Lance) Hu, Ph.D, a Vice President at United Imaging Healthcare America, who will be honored as a 2023 Distinguished Investigator at RSNA.
  • RSNA attendees are invited to experience the future of medical imaging at Booth #4100, where United Imaging continues to bridge innovation and patient care through state-of-the-art technologies.

Increasing Incidence of Kidney Stone Disease Drives Growth in Stone Management Disposables Market, with Calcium Oxalate Stones Dominating - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 8, 2023

The model discusses in detail the impact of COVID-19 on Stone Management Disposables market for the year 2020 and beyond.

Key Points: 
  • The model discusses in detail the impact of COVID-19 on Stone Management Disposables market for the year 2020 and beyond.
  • Nephrolithiasis, or kidney stone disease, is a condition in which individuals form stones in the kidney or urinary tract.
  • Kidney stones can be classified based on their chemical composition: calcium oxalate, calcium phosphate, uric acid, cysteine, struvite.
  • Calcium oxalate stones are the most commonly formed stones and account for approximately 82% of stone cases.

Phathom Pharmaceuticals Announces FDA Approval of Reformulated Vonoprazan Tablets for VOQUEZNA® TRIPLE PAK® (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA® DUAL PAK® (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults

Retrieved on: 
Monday, October 30, 2023

The full Prescribing Information for VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK can be found here.

Key Points: 
  • The full Prescribing Information for VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK can be found here.
  • VOQUEZNA® TRIPLE PAK® (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA® DUAL PAK® (vonoprazan tablets, amoxicillin capsules) are co-packaged prescription medicines for the treatment of a Helicobacter pylori (H. pylori) bacterial infection in adults.
  • It is not known if VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK are safe and effective in children.
  • Stop taking VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK if you are diagnosed with mononucleosis and call your doctor right away.

Total Health Link Leads the Charge in At-Home Health Practices: Burlington's Premier Chiropractic and Physiotherapy Experts Share Home Health Tips

Retrieved on: 
Monday, November 6, 2023

Psoas Stretch: In a lunge position, with one knee on the ground, tilt your pelvis forward to stretch the front of your hip on the kneeling side.

Key Points: 
  • Psoas Stretch: In a lunge position, with one knee on the ground, tilt your pelvis forward to stretch the front of your hip on the kneeling side.
  • Hamstring Stretch: Seated on the ground, extend one leg out and reach toward your toes while keeping your back straight.
  • Glute Stretch: While seated, cross one ankle over the opposite knee and gently press down on the crossed knee.
  • Pelvic Tilts: Lying on your back with knees bent, flatten your back against the floor by tightening your abdominal muscles and tilting your pelvis.

Medical Spa Expert Sei Tu Bella Aesthetics Joins Exclusive Haute Beauty Network

Retrieved on: 
Tuesday, October 31, 2023

NEW YORK, Oct. 31, 2023 /PRNewswire-PRWeb/ -- Heather Merlo, APRN, FNP-C, is a board-certified family nurse practitioner, serving over 15 years in acute care and emergency medicine at Tampa General Hospital, a level 1 trauma center in Tampa, Florida. At seven months pregnant and facing the wall of the pandemic in 2021, Merlo embarked on the transition from corporate world America to women entrepreneurship. Fueled by the desire to balance the life of a Mother and her role as a women entrepreneur, increasing the confidence in women and striving for regenerative medicine and achieving optimal wellness, especially in light of the pandemic, Sei Tu Bella Aesthetics was founded. With no backup plan, Merlo turned her dreams into reality to pursue her love of aesthetic medicine and empower women by providing an emphasis on women's wellness services.

Key Points: 
  • Sei Tu Bella Aesthetics joins Haute Beauty Network as a medical spa expert representing the Tampa, FL market.
  • Prior to becoming an independent practitioner, she received specialized training in medical aesthetics at AMET and the top leaders in the industry, such as Merz Pharmaceuticals, Galderma, Allergan, Crown Aesthetics, Revive, and Inmode.
  • As the first Nurse Practitioner-owned MedSpa in the state of Florida to feature the Empower RF platform by Inmode, Sei Tu Bella Aesthetics became Lutz's premiere women's wellness institute.
  • Learn more about Sei Tu Bella Aesthetics by visiting: https://hauteliving.com/hautebeauty/member/sei-tu-bella-aesthetics/

Pleural Dynamics Receives FDA 510(k) Clearance for its Novel ACES™ Automatic Continuous Effusion Shunt System

Retrieved on: 
Thursday, October 19, 2023

Pleural Dynamics, a medical device company that is building solutions for chronic, recurrent fluid collections in the body, today announced that the Company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ACES™ Automatic Continuous Effusion Shunt System.

Key Points: 
  • Pleural Dynamics, a medical device company that is building solutions for chronic, recurrent fluid collections in the body, today announced that the Company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ACES™ Automatic Continuous Effusion Shunt System.
  • Pleural Dynamics’ patented ACES™ System addresses these shortcomings1 with its’ one-piece, fully implanted system that can be placed during a short hospital stay.
  • With this FDA 510(k) clearance, Pleural Dynamics will begin real-world clinical use of the ACES™ System with select hospitals and health systems.
  • Pleural Dynamics’ latest technology will play a vital role in improving the lives of patients with intractable pleural effusion.

AirSculpt® Technologies, Inc. Announces Partnership with Singer and TV Personality, Joey Fatone to Transform his Body with AirSculpt

Retrieved on: 
Tuesday, October 17, 2023

MIAMI BEACH, Fla., Oct. 17, 2023 (GLOBE NEWSWIRE) -- AirSculpt® Technologies, Inc., (“AirSculpt”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, is partnering with singer, dancer, actor, and TV personality Joey Fatone to share his AirSculpt® experience.

Key Points: 
  • MIAMI BEACH, Fla., Oct. 17, 2023 (GLOBE NEWSWIRE) -- AirSculpt® Technologies, Inc., (“AirSculpt”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, is partnering with singer, dancer, actor, and TV personality Joey Fatone to share his AirSculpt® experience.
  • Joey had AirSculpt® on his full abdomen to remove the stubborn fat hiding his abs, waist, and obliques and to help him achieve a more chiseled jawline.
  • I can’t believe I’m already seeing the changes to my body and now I feel like I WANT to work out.
  • For additional information on AirSculpt or for information about scheduling a virtual or in-person consultation at any of the 27 centers, visit airsculpt.com.

HALO Precision Diagnostics Collaborating with Bayer to Advance Contrast-Enhanced MRI

Retrieved on: 
Tuesday, October 17, 2023

HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, ​​a global leader in radiology, to join QUANTI, Bayer’s Phase III clinical development program for gadoquatrane.

Key Points: 
  • HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, ​​a global leader in radiology, to join QUANTI, Bayer’s Phase III clinical development program for gadoquatrane.
  • Bayer initiated the QUANTI studies to evaluate the safety and efficacy of gadoquatrane, an investigational gadolinium-based contrast agent, in MRI.
  • Contrast-enhanced MRI plays a key role in the healthcare continuum, providing a radiation-free imaging method to obtain detailed images of the body.
  • “Our partnership with Bayer is the latest example of HALO leading the way when it comes to advancements supporting early disease detection,” said Bernadette Greenwood, chief research officer, HALO.